February 16, 2023
1 min read
Save
BrigHTN
Issue: February 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Efficacy and safety of multiple dose strengths of baxdrostat vs. placebo in treatment-resistant hypertension.